Literature DB >> 14304247

FIBRINOLYSIS AND CARCINOMA OF THE PROSTATE.

H T SWAN, D F KERRIDGE.   

Abstract

In a series of 68 patients suffering from carcinoma of the prostate, plasma fibrinolytic activity has been found to be similar to that in control groups. Some comments have been made on the problem of fibrinolysis and bleeding associated with carcinoma of the prostate, with the suggestion that the part played by fibrinolysis has been over-emphasized.

Entities:  

Keywords:  FIBRINOLYSIS; GERIATRICS; HEMORRHAGE; PROSTATIC NEOPLASMS

Mesh：

Year:  1965        PMID： 14304247      PMCID： PMC472935          DOI： 10.1136/jcp.18.3.330

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN： 0021-9746            Impact factor:   3.411


  8 in total

1.  Coexistent hypercoagulability and acute hypofibrinogenemia in a patient with prostatic carcinoma.

Authors:  S I RAPAPORT; C G CHAPMAN
Journal:  Am J Med       Date:  1959-07       Impact factor: 4.965

2.  Dangerous bleeding associated with carcinoma of prostate.

Authors:  O DANIEL; H T SWAN; K F WOOD
Journal:  Br Med J       Date:  1957-03-02

3.  Acute hemorrhagic syndrome with hypofibrinogenemia in metastatic cancer.

Authors:  P G FRICK
Journal:  Acta Haematol       Date:  1956-07       Impact factor: 2.195

4.  The fibrinolytic activity of normal blood.

Authors:  G R FEARNLEY; R LACKNER
Journal:  Br J Haematol       Date:  1955-04       Impact factor: 6.998

5.  Prostatic fibrinolysin; study of a case illustrating role in hemorrhagic diathesis of cancer of the prostate.

Authors:  H J TAGNON; P SCHULMAN; W F WHITMORE; L A LEONE
Journal:  Am J Med       Date:  1953-12       Impact factor: 4.965

6.  Factor 5 deficiency in hemorrhagic diathesis (parahemophilia).

Authors:  S W COSGRIFF; E LEIFER
Journal:  J Am Med Assoc       Date:  1952-02-09

7.  Clotting defect in the presence of metastatic carcinoma of prostate; a case report.

Authors:  R A SEALE; R W JAMPOLIS; J A BARGEN
Journal:  Surg Clin North Am       Date:  1951-08       Impact factor: 2.741

8.  [Fatal hemorrhagic syndromes with total incoagulability and with fibrinolysis; in pulmonary exeresis].

Authors:  J P SOULIER; J MATHEY; A G LE BOLLOCK; P DAUMET; H FAYET
Journal:  Rev Hematol       Date:  1952
  8 in total
  1 in total

1.  Fibrinolytic activity in malignant disease.

Authors:  J A Rennie; D Ogston
Journal:  J Clin Pathol       Date:  1975-11       Impact factor: 3.411
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.